Infectious Disease Alert – November 1, 2010
November 1, 2010
View Issues
-
Olsetamivir for Children 1-3 Years of Age
A randomized, double-blind, placebo-controlled trial of the efficacy of oral oseltamivir twice daily started within 24 hours of onset of influenza symptoms (fever, plus cough, rhinitis, or sore throat) was conducted in children 1-3 years of age at a single primary care study site in Finland during the 2007-2008 and 2008-2009 influenza seasons. -
Trading Kidney Disease for Protection from Trypanosomiasis
Initial association analysis was performed on 205 african-americans with biopsy-proven FSGS and 180 African-American controls. -
Pertusis Prevention
The introduction of accellular pertussis vaccines represented an important advance in public health, but developing a vaccine is not synonymous with protecting a population. -
Antibiotic Use During Pregnancy and Risk of Birth Defects
The purpose of this study was to estimate the association between antibacterial medications and selected birth defects. -
Updates on Recommendations for Use of Human Papillomavirus Vaccines
In October 2009, the FDA licensed the bivalent human papillomavirus vaccine (HPV2; Cervarix, GlaxoSmithKline) for use in females aged 10 through 25 years. -
Tungiasis Painful Feet in a Tropical Traveler
A 39-year-old man had traveled for four weeks to the Pantanal region of Brazil, a popular ecotourism area, where he had walked barefoot on several occasions. -
Updates by Carol A. Kemper, MD, FACP
Although there is little data to support this, I routinely counsel my HIV-infected patients to get seasonal and H1N1 vaccine, explaining that while they are probably at no greater risk for "catching the flu," they may be at greater risk for more severe symptoms and complications than someone without HIV. -
Pharmacology Watch: Dabigatran Leading Race to Replace Warfarin
In this issue: FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions. -
Clinical Briefs in Primary Care supplement